Author: plst.main

On 15-17th October 2024, Cherry Biotech participated in the Festival of Biologics in Basel, Switzerland, Europe’s largest biologics event. Cherry Biotech presented the PLAST_CELL project and their latest innovative CubiX prototype, designed to confine cells and precisely control environmental conditions. This novel tool, combined with the data currently generated by the PLAST_CELL consortium, will enable to quantify phenotypic changes in cancer cells, shedding light on cancer cell plasticity and aggressiveness.

At the event, Cherry Biotech had the chance to connect with top-tier biologists and researchers from leading pharmaceutical and biotech companies, discussing the future of preclinical trials and personalized medicine. The primary focus: how CubiX can enhance efficacy and enable the change from animal models to 3D cell culture.

On 5 th May 2022, we held a virtual Kick-off Meeting of our project that is funded by a European Innovation Council (EIC) Pathfinder Grant. The interdisciplinary consortium is formed by 5 partners: CRG, ICFO, IMIM, EMBL-EBI and Cherry Biotech. Together, we will pioneer the development of a microfluidics- based imaging platform to study cancer cell plasticity for a new era of basic research and personalized medicine.

After a general round of introductions, the participants focused on Research Data Management, since a lot of microscopy image data will be generated and analyzed. Other actions were agreed upon, such as scheduling weekly online meetings and working out the structure of the PLAST_CELL website. The virtual Kick-off meeting left everyone wanting to meet in person soon. We are excited about the challenge of making this 4-year project a reality!